PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair.

Konstantinopoulos, Panagiotis A

PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair. [electronic resource] - American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting Mar 2020 - 1-16 p. digital

Publication Type: Journal Article; Review

1548-8756

10.1200/EDBK_288015 doi


Animals
DNA Damage
DNA Repair
Drug Therapy, Combination
Female
Humans
Ovarian Neoplasms--drug therapy
Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use